{
  "catalogId": "958ea3ce-87fd-4163-a125-5d2f4c942cd0",
  "name": "TRIUMEQ",
  "status": "draft",
  "category": "29C",
  "registrationValidity": "valid",
  "registrationNumber": "153 49 34304 00",
  "treatmentDescriptions": "Triumeq is indicated for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age weighing at least 40 kg.Before initiating treatment with abacavir-containing products, screening for carriage of the HLA-B*5701 allele should be performed in any HIV-infected patient, irrespective of racial origin. Abacavir should not be used in patients known to carry the HLA-B*5701 allele.",
  "termsOfIssue": "",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "DOLUTEGRAVIR AS SODIUM, ABACAVIR AS SULFATE, LAMIVUDINE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "J05AR13",
      "name": "LAMIVUDINE AND ABACAVIR AND DOLUTEGRAVIR"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "30 MEQ POT.CHL 5% DEX 0.45% SOD.CHL 1L INJ",
      "manufacturer": {
        "name": "",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "21023",
        "barcode": "7290014547155"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": "",
        "retailMargin": "",
        "maxRetailPrice": "",
        "maxPriceWithVAT": ""
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.802400"
  }
}